CAGT hero 2

Leaders in Developing and Applying Genomic Technologies

The Genomic Revolution promises the discovery of targeted approaches for treating disease. Innovations like CRISPR-based genome editing and comprehensive epigenomic profiling can inform, streamline and accelerate drug target discoveries, but piecing together this complex puzzle requires an interdisciplinary approach.

The Center for Advanced Genomic Technologies (CAGT) has assembled a team of world-leading engineers, scientists and physicians to integrate these technologies to unravel disease biology and discover new drug targets. By working together, we will catalyze a more robust biotechnology enterprise.

In the News

i3N iPSC-derived human neurons at 21 DPI. Nuclei are stained with DAPI, neurons are marked by Tubulin, and glutamatergic synapses by PSD95

October 7, 2021

West receives grant from Ruth K. Broad Research Foundation for Alzheimer research

Anne West, MD, PhD, professor of neurobiology, received a Faculty Scholar Award from the Ruth K Broad Biomedical Research Foundation to study noncoding regulation of gene transcription in human neurons. This three-year, $375,000 grant will leverage what researchers already know about cellular [...]

Charlie Gersbach, Greg Crawford, Tim Reddy, Andrew Allen, David Page, Sayan Mukherjee

September 9, 2021

Two new NIH-funded centers to explore impacts of genomic variation in health, disease

Duke University is the recipient of two large grants totaling nearly $12 million from NHGRI.